08048036315
Mounjaro 5mg Inj affordable tablets to USA -New York,LA,Chicago,Houston|Phoenix Exim|Trusted Exporte

Tirzepatide 5 mg Injection | Once-Weekly Prescription Medicine for Type 2 Diabetes

Phoenix Exim – Pharmaceutical Exporter from Nagpur, India

Phoenix Exim offers pharmaceutical products from Nagpur, India for international B2B requirements, including markets such as USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable import, registration, prescription, labeling, customs, and regulatory requirements.


1. 🌟 GENERAL INFORMATION

Mounjaro 5 mg Prefilled Pen contains tirzepatide 5 mg, a once-weekly injectable medicine belonging to the GIP and GLP-1 receptor agonist class.

In the U.S. prescribing information, Mounjaro is indicated as an adjunct to diet and exercise to improve blood-glucose control in adults with type 2 diabetes mellitus.

Tirzepatide works through two incretin pathways, helping regulate glucose-dependent insulin secretion, glucagon levels, food intake, and body weight.

✦ Product Highlights

  • Active Ingredient: Tirzepatide

  • Strength: 5 mg

  • Dosage Form: Injection

  • Device: Prefilled Pen

  • Route: Subcutaneous injection

  • Frequency: Once weekly

  • Therapeutic Class: GIP / GLP-1 receptor agonist

  • Manufacturer/Brand: Mounjaro

  • Supply Base: Nagpur, Maharashtra, India


2. πŸ’Ž PRODUCT INFORMATION

Product DetailInformation
Brand NameMounjaro
Active IngredientTirzepatide
Strength5 mg
Dosage FormInjectable Solution
PresentationPrefilled Pen
RouteSubcutaneous
FrequencyOnce weekly
Therapeutic CategoryGIP / GLP-1 Receptor Agonist
Primary U.S. IndicationType 2 Diabetes Mellitus
Country of SupplyIndia
ExporterPhoenix Exim
Supply LocationNagpur, Maharashtra, India

The FDA labeling identifies Mounjaro as a clear, colorless to slightly yellow, sterile solution for subcutaneous use. The 5 mg presentation contains 5 mg tirzepatide in 0.5 mL in the U.S. labeling.


3. 🎯 USES OF MOUNJARO 5 MG

πŸ”Ή Type 2 Diabetes Management

Mounjaro is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

πŸ”Ή Blood-Glucose Control

Tirzepatide helps regulate glucose metabolism through glucose-dependent effects on insulin and glucagon.

πŸ”Ή Appetite & Food Intake

Tirzepatide can reduce food intake and is associated with reductions in body weight in patients with type 2 diabetes.

Important: The approved indications and product labeling can differ between countries. Buyers should always check the current authorization in their destination market.


4. ⭐ BENEFITS OF MOUNJARO 5 MG

When appropriately prescribed and used, tirzepatide may provide several therapeutic benefits:

βœ… Helps improve blood-glucose control
βœ… Works through both GIP and GLP-1 receptor pathways
βœ… Enhances glucose-dependent insulin secretion
βœ… Reduces glucagon levels in a glucose-dependent manner
βœ… Helps reduce food intake
βœ… Can contribute to body-weight reduction
βœ… Convenient once-weekly administration
βœ… Available in a prefilled injection presentation

Tirzepatide's dual GIP/GLP-1 activity distinguishes it pharmacologically from medicines that activate only one of these incretin pathways.


5. ⚠️ SIDE EFFECTS OF MOUNJARO 5 MG

Mounjaro can cause gastrointestinal and other adverse reactions.

Possible side effects include:

  • Nausea

  • Diarrhea

  • Decreased appetite

  • Vomiting

  • Constipation

  • Indigestion / dyspepsia

  • Abdominal pain

  • Injection-site reactions

The FDA prescribing information identifies nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain among the most common adverse reactions.

Some adverse reactions may be more noticeable during dose escalation.


6. πŸ”Έ COMMON SIDE EFFECTS

The commonly reported reactions include:

Nausea | Diarrhea | Decreased Appetite | Vomiting | Constipation | Dyspepsia | Abdominal Pain

These effects can vary in intensity between individuals.

If severe or persistent gastrointestinal symptoms occur, medical advice should be sought.


7. πŸ“‹ HOW TO USE MOUNJARO 5 MG PREFILLED PEN

Mounjaro is administered subcutaneously once weekly according to the prescribing instructions. The U.S. label specifies injection into the abdomen, thigh, or upper arm, with injection sites rotated.

General Administration

STEP 1 β€” Check the Pen
Inspect the pen according to the manufacturer's instructions before use.

STEP 2 β€” Select Injection Site
The approved injection sites include the abdomen, thigh, or upper arm.

STEP 3 β€” Administer Subcutaneously
Inject under the skin, not into a vein or muscle.

STEP 4 β€” Follow the Prescribed Schedule
Mounjaro is generally administered once weekly. The exact dose-escalation schedule should be determined by the prescribing healthcare professional.

STEP 5 β€” Rotate Injection Sites
Rotate injection locations to reduce repeated irritation at the same site.

The U.S. prescribing information recommends 2.5 mg once weekly as the starting dose, followed by 5 mg once weekly after four weeks; further increases, when needed, are made in 2.5 mg increments after at least four weeks at the current dose.

⚠️ Important

Do not change the dose or injection schedule without medical supervision.


8. βš™οΈ HOW DOES MOUNJARO WORK?

Mounjaro contains tirzepatide, which activates both the GIP receptor and GLP-1 receptor.

🧬 Dual Incretin Action

Tirzepatide activates two incretin pathways involved in glucose regulation.

πŸ’‰ Supports Insulin Secretion

It enhances first- and second-phase insulin secretion in a glucose-dependent manner.

πŸ“‰ Reduces Glucagon

Tirzepatide reduces glucagon levels in a glucose-dependent manner.

🍽️ Influences Food Intake

The medicine decreases food intake and is associated with reductions in body weight in people with type 2 diabetes.

πŸ•’ Prolonged Action

Its molecular structure includes a fatty-acid component that supports albumin binding and contributes to its prolonged half-life, allowing once-weekly administration.


9. πŸ›‘οΈ SAFETY ADVICE

⚠️ Thyroid Tumor Warning

Mounjaro carries a boxed warning regarding the risk of thyroid C-cell tumors observed in rats. The human relevance is unknown.

It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

🩺 Pancreatitis

Acute pancreatitis has been observed. Seek medical evaluation if symptoms suggestive of pancreatitis occur.

🍽️ Gastrointestinal Problems

Mounjaro can cause gastrointestinal adverse reactions and is not recommended for patients with severe gastroparesis.

πŸ’§ Kidney Function

Significant gastrointestinal reactions can contribute to dehydration and may lead to acute kidney injury. Appropriate medical monitoring may be required.

πŸ’Š Hypoglycemia

The risk of hypoglycemia can increase when Mounjaro is used with insulin or insulin secretagogues.

πŸ¦‹ Gallbladder Problems

Acute gallbladder disease has been reported. Seek medical evaluation if symptoms suggestive of gallbladder disease occur.

πŸ‘οΈ Diabetic Retinopathy

Patients with a history of diabetic retinopathy may require monitoring for progression.

🀰 Pregnancy

Mounjaro may cause fetal harm based on animal studies. Discuss pregnancy, pregnancy planning, or breastfeeding with a healthcare professional before treatment.

πŸ’Š Oral Medicines

Because tirzepatide delays gastric emptying, it can potentially affect absorption of certain oral medicines.

πŸ₯ Surgery / Anesthesia

Patients should inform healthcare professionals about Mounjaro treatment before planned surgery or procedures involving general anesthesia or deep sedation because delayed gastric emptying may increase aspiration risk.

❄️ Storage

For the U.S. single-dose pen presentation, Mounjaro should generally be refrigerated at 2Β°C–8Β°C (36Β°F–46Β°F). If necessary, a single-dose pen may be kept at temperatures up to 30Β°C (86Β°F) for up to 21 days. Do not freeze. Keep it in the original carton to protect it from light.

Always follow the storage instructions supplied with the specific product presentation.


10. ❓ FREQUENTLY ASKED QUESTIONS

Q1. What is Mounjaro 5 mg?

Mounjaro 5 mg is an injectable medicine containing tirzepatide 5 mg, administered subcutaneously.

Q2. What is Mounjaro used for?

In the U.S., Mounjaro is indicated with diet and exercise to improve blood-glucose control in adults with type 2 diabetes.

Q3. How often is Mounjaro 5 mg administered?

Mounjaro is administered once weekly according to the prescribed treatment schedule.

Q4. Where is Mounjaro injected?

It is injected subcutaneously into the abdomen, thigh, or upper arm, with injection sites rotated.

Q5. Is Mounjaro a GLP-1 medicine?

Tirzepatide activates both GIP and GLP-1 receptors, so it is a dual GIP/GLP-1 receptor agonist.

Q6. What are the common side effects?

Common adverse reactions include nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain.

Q7. Can Mounjaro be used with insulin?

It may be used in certain treatment plans, but concomitant use with insulin can increase the risk of hypoglycemia. Dose adjustments may be required under medical supervision.

Q8. Who should not use Mounjaro?

It is contraindicated in people with a personal or family history of MTC, MEN 2, or a serious hypersensitivity to tirzepatide or its ingredients.

Q9. Does Mounjaro require refrigeration?

The U.S. single-dose pen should generally be refrigerated at 2Β°C–8Β°C. Specific temporary room-temperature allowances apply according to the U.S. labeling.

Q10. Can Mounjaro 5 mg be exported internationally?

International pharmaceutical requirements differ by country. Buyers should verify registration, prescription status, import authorization, cold-chain requirements, labeling, documentation, customs procedures, and applicable destination-country regulations before purchasing.


11. πŸ”„ SUBSTITUTE / ALTERNATIVES FOR MOUNJARO 5 MG

There is no universal one-to-one substitute for Mounjaro 5 mg.

Potential therapeutic alternatives may include medicines from related or different classes, depending on the patient's diagnosis and treatment plan, such as:

  • Other tirzepatide-containing products where legally approved

  • GLP-1 receptor agonist medicines

  • Other glucose-lowering medicines

  • Insulin-based therapies

  • Other physician-selected treatments for type 2 diabetes

⚠️ Important

A different medicine, active ingredient, strength, or formulation is not automatically equivalent to Mounjaro 5 mg.

Any substitution should be determined by a qualified healthcare professional based on the patient's medical history, glucose control, other medicines, contraindications, and applicable local prescribing guidance.


12. πŸ”Ž SEO KEYWORDS

πŸš€ Primary Product Keywords

  1. Mounjaro 5 mg Prefilled Pen

  2. Mounjaro 5 mg Injection

  3. Mounjaro 5 mg Pen

  4. Tirzepatide 5 mg Injection

  5. Tirzepatide 5 mg Pen

  6. Mounjaro 5 mg supplier

  7. Mounjaro 5 mg exporter India

  8. Tirzepatide injection supplier

  9. Tirzepatide pharmaceutical exporter

  10. Mounjaro pharmaceutical supplier

🌍 International B2B Keywords

  1. Mounjaro 5 mg exporter from India

  2. Tirzepatide 5 mg supplier India

  3. Tirzepatide injection exporter India

  4. Mounjaro prefilled pen supplier

  5. Tirzepatide prefilled pen exporter

  6. Injectable diabetes medicine supplier India

  7. Diabetes medicine B2B exporter

  8. Pharmaceutical injection exporter Nagpur

  9. Tirzepatide international supplier

  10. Mounjaro pharmaceutical export India

🌎 Country-Focused Keywords

  1. Mounjaro supplier USA

  2. Mounjaro supplier UK

  3. Mounjaro supplier Australia

  4. Mounjaro supplier Canada

  5. Mounjaro supplier Singapore

  6. Mounjaro supplier South Korea

  7. Mounjaro supplier UAE

  8. Tirzepatide supplier USA

  9. Tirzepatide supplier UK

  10. Tirzepatide supplier Australia

  11. Tirzepatide supplier Canada

  12. Tirzepatide supplier Singapore

  13. Tirzepatide supplier South Korea

  14. Tirzepatide supplier UAE

  15. Nagpur pharmaceutical exporter

πŸ”₯ Long-Tail SEO Keywords

  1. Mounjaro 5 mg Prefilled Pen pharmaceutical exporter from India

  2. Tirzepatide 5 mg injection international B2B supplier

  3. Mounjaro 5 mg injectable medicine supplier India

  4. Tirzepatide 5 mg prefilled pen pharmaceutical exporter

  5. Mounjaro 5 mg supplier from Nagpur India

  6. Tirzepatide diabetes injection international supplier

  7. Mounjaro 5 mg pharmaceutical B2B exporter

  8. Tirzepatide injectable product exporter from India

  9. Type 2 diabetes injectable medicine supplier India

  10. Tirzepatide 5 mg global pharmaceutical supply

🏒 Phoenix Exim Keywords

  1. Phoenix Exim pharmaceutical exporter

  2. Phoenix Exim medicine exporter Nagpur

  3. Phoenix Exim Mounjaro supplier

  4. Phoenix Exim Tirzepatide supplier India

  5. Phoenix Exim diabetes medicine exporter


🌐 PHOENIX EXIM β€” INTERNATIONAL PHARMACEUTICAL SUPPLY

Mounjaro 5 mg Prefilled Pen | Tirzepatide Injection

Phoenix Exim
Pharmaceutical Exporter from Nagpur, India

🌎 International B2B Supply Support:
πŸ‡ΊπŸ‡Έ USA | πŸ‡¬πŸ‡§ UK | πŸ‡¦πŸ‡Ί Australia | πŸ‡ΈπŸ‡¬ Singapore | πŸ‡¨πŸ‡¦ Canada | πŸ‡°πŸ‡· South Korea | πŸ‡¦πŸ‡ͺ UAE


Aug 10th, 2026 4:19 PM

Keywords